Asia Pacific In Vitro Diagnostics Market

Asia Pacific In Vitro Diagnostics Market by Technologies (Microbiology, Clinical Chemistry, Molecular Diagnosis, Coagulation, Hematology, and Immunoassays), Applications (Autoimmune Diseases, Cardiology, Infectious Diseases, HIV, Nephrology, Drug Testing, and Oncology), Product Types (Instruments, Services, and Reagents), End-users (Homecare Diagnostics, Laboratories, Hospitals, and Others), and Geography (Japan, India, China, and Rest of Asia Pacific) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-2986
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 230
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Asia Pacific in vitro diagnostics market size is estimated to expand at a considerable CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing occurrence of chronic illness and infectious diseases along with the growing recognition levels of advanced diagnostic solutions.

Asia Pacific In Vitro Diagnostics Market

In vitro diagnostics (IVD) are tests conducted on tissue or blood in order to detect diseases and other illness of a patient. The use of the diagnostic can help to provide effective treatment of diseases to enhance the chance of cure. Moreover, IVD is widely used to determine range of benefits or certain challenges in terms of applying certain therapies or specific treatments. It also includes several advanced process such as next generation sequencing tests, which can examine a person’s DNA to detect genetic disparity.

Market Trends, Drivers, Restraints, and Opportunities

  • Rapid advancement in innovative technology and availability of sophisticated diagnostic solutions are expected to boost the market in the coming years.
  • Increasing investment in healthcare settings in emerging countries due to high prevalence of chronic illness is a key driver of the market.
  • Introduction of advanced technology and wide use of Point-of-Care (POC) diagnostics in in-vitro products present a major factor driving the market.
  • Strict government rules for the approval of devices or products and issues regarding complex reimbursement policies are major restraining factors of the market. 
  • Rising awareness among people and acceptance of personalized medicine with the wide adoption of companion diagnostics are major factors offering several growth opportunities of the market.

Scope of the Report

The report on the Asia Pacific in vitro diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Asia Pacific In Vitro Diagnostics Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Technologies (Microbiology, Clinical Chemistry, Molecular Diagnosis, Coagulation, Hematology, and Immunoassays), Applications (Autoimmune Diseases, Cardiology, Infectious Diseases, HIV, Nephrology, Drug Testing, and Oncology), Product Types (Instruments, Services, and Reagents), and End-users (Homecare Diagnostics, Laboratories, Hospitals, and Others)

Geography

Japan, India, China, and Rest of Asia Pacific

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Becton, Dickinson and Company; Affymetrix, Inc.; BioMerieux, Inc.; Danaher Corporation; Alere, Inc.; Roche Diagnostics; Bio-Rad Laboratories, Inc.;  Abbott Laboratories, Inc.; Siemens Healthcare Diagnostics, Inc.; and Vela Diagnostics, Inc.

Market Segment Insights

Clinical chemistry segment to expand at a considerable CAGR

On the basis of technologies, the market is segregated into microbiology, clinical chemistry, molecular diagnosis, coagulation, hematology, and immunoassays. The clinical chemistry segment is projected to expand at a considerable CAGR during the forecast period. The rising in adoption of the molecular tests and wide adoption of clinical chemical technology for the majority of the diseases are key drivers of the segment. On the other hand, the microbiology segment is anticipated to account for a major market share during the forecast period. Rising adoption of tests conducted by organizations to enhance patient outcomes using rapid diagnostic techniques and cost-effective presents a key driver of the segment.

Asia Pacific In Vitro Diagnostics Market

Infectious diseases segment to account for large revenue share

Based on applications, the Asia Pacific in vitro diagnostics market is divided into autoimmune diseases, cardiology, infectious diseases, HIV, nephrology, drug testing, and oncology. The infectious diseases segment is expected to account for large revenue share during the forecast period owing to the increasing awareness among people regarding the easy accessibility of these automation advanced diagnostics for the treatment of infectious diseases. However, the cardiology segment is anticipated to hold a key share of the market in the coming years due to the existence of unfulfilled healthcare and favorable government initiatives regarding the treatment of heart patients.

Instruments segment to grow at a rapid pace

Based on product types, the market is divided into services, instruments, and reagents. The instruments segment is expected to grow at a rapid pace during the forecast period due to the availability of a wide range of diagnostics kits and the extensive use of instrument or devices for disease treatments. However, the reagents segment is anticipated to hold a key share of the market in the coming years owing to increasing demand for advanced reagents in the IVD market.

Asia Pacific In Vitro Diagnostics Market

Homecare diagnostics segment to register a high CAGR

On the basis of end-users, the Asia Pacific in vitro diagnostics market is fragmented into homecare diagnostics, laboratories, hospitals, and others. The homecare diagnostics segment is anticipated to register a high CAGR during the forecast period due to the rising number of initiatives to decrease hospital stays as well as growing demand for rapid diagnostic tests at home. However, the laboratories segment is anticipated to hold a key share of the market in the coming years due to the wide laboratory experiment of IVD.

China is anticipated to constitute a key market share

In terms of regions, the market is classified as Japan, India, China, and Rest of Asia Pacific. China is expected to constitute a key share of the market during the projected period due to the rising healthcare expenditure and GDP growth in the country. However, the market of India is anticipated to expand at a rapid pace during the forecast period owing to growing number of the population base, growing high demand for the testing of outpatients, and medical coverage.

Asia Pacific In Vitro Diagnostics Market

Segments

Segments Covered in the Report

The Asia Pacific in vitro diagnostics market has been segmented on the basis of

Technologies

  • Microbiology
  • Clinical Chemistry
  • Molecular Diagnosis
  • Coagulation
  • Hematology
  • Immunoassays

Applications

  • Autoimmune Diseases
  • Cardiology
  • Infectious Diseases
  • HIV
  • Nephrology
  • Drug Testing
  • Oncology

 Product Types

  • Instruments
  • Services
  • Reagents

End-users

  • Homecare Diagnostics
  • Laboratories
  • Hospitals
  • Others

Geography

  • Japan
  • India
  • China
  • Rest of Asia Pacific

Key Players

  • Becton, Dickinson and Company
  • Affymetrix, Inc.
  • BioMerieux, Inc.
  • Danaher Corporation
  • Alere, Inc.
  • Roche Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Abbott Laboratories, Inc.
  • Siemens Healthcare Diagnostics, Inc.
  • Vela Diagnostics, Inc.

Competitive Landscape

Key players competing in the Asia Pacific in vitro diagnostics market are  Becton, Dickinson and Company; Affymetrix, Inc.; BioMerieux, Inc.; Danaher Corporation; Alere, Inc.; Roche Diagnostics; Bio-Rad Laboratories, Inc.;  Abbott Laboratories, Inc.; Siemens Healthcare Diagnostics, Inc.; and Vela Diagnostics, Inc.

The companies were majorly competing in the development of new products through extensive R&D activities. For instance, in March 2016, Cepheid announced its FDA hold with test ‘XpertCarba-R’, an in vitro diagnostic test that sanction successful search of carbapenem resistance genes.

Asia Pacific In Vitro Diagnostics Market

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. In Vitro Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. In Vitro Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. In Vitro Diagnostics Market - Supply Chain
  4.5. Global In Vitro Diagnostics Market Forecast
     4.5.1. In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. In Vitro Diagnostics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. In Vitro Diagnostics Market Absolute $ Opportunity
5. Global In Vitro Diagnostics Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. In Vitro Diagnostics Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global In Vitro Diagnostics Demand Share Forecast, 2019-2026
6. North America In Vitro Diagnostics Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America In Vitro Diagnostics Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America In Vitro Diagnostics Demand Share Forecast, 2019-2026
7. Latin America In Vitro Diagnostics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America In Vitro Diagnostics Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America In Vitro Diagnostics Demand Share Forecast, 2019-2026
8. Europe In Vitro Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe In Vitro Diagnostics Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe In Vitro Diagnostics Demand Share Forecast, 2019-2026
9. Asia Pacific In Vitro Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific In Vitro Diagnostics Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific In Vitro Diagnostics Demand Share Forecast, 2019-2026
10. Middle East & Africa In Vitro Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa In Vitro Diagnostics Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa In Vitro Diagnostics Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global In Vitro Diagnostics Market: Market Share Analysis
  11.2. In Vitro Diagnostics Distributors and Customers
  11.3. In Vitro Diagnostics Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)

Segments Covered in the Report

The Asia Pacific in vitro diagnostics market has been segmented on the basis of

Technologies

  • Microbiology
  • Clinical Chemistry
  • Molecular Diagnosis
  • Coagulation
  • Hematology
  • Immunoassays

Applications

  • Autoimmune Diseases
  • Cardiology
  • Infectious Diseases
  • HIV
  • Nephrology
  • Drug Testing
  • Oncology

 Product Types

  • Instruments
  • Services
  • Reagents

End-users

  • Homecare Diagnostics
  • Laboratories
  • Hospitals
  • Others

Geography

  • Japan
  • India
  • China
  • Rest of Asia Pacific

Key Players

  • Becton, Dickinson and Company
  • Affymetrix, Inc.
  • BioMerieux, Inc.
  • Danaher Corporation
  • Alere, Inc.
  • Roche Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Abbott Laboratories, Inc.
  • Siemens Healthcare Diagnostics, Inc.
  • Vela Diagnostics, Inc.

Key players competing in the Asia Pacific in vitro diagnostics market are  Becton, Dickinson and Company; Affymetrix, Inc.; BioMerieux, Inc.; Danaher Corporation; Alere, Inc.; Roche Diagnostics; Bio-Rad Laboratories, Inc.;  Abbott Laboratories, Inc.; Siemens Healthcare Diagnostics, Inc.; and Vela Diagnostics, Inc.

The companies were majorly competing in the development of new products through extensive R&D activities. For instance, in March 2016, Cepheid announced its FDA hold with test ‘XpertCarba-R’, an in vitro diagnostic test that sanction successful search of carbapenem resistance genes.

Asia Pacific In Vitro Diagnostics Market

Buy Report